Clinical Trial

Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation

Study acronym: COATING
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To assess safety and efficacy of p64 MW HPC Flow Modulation Device under single antiplatelet therapy compared to p64 MW Flow Modulation Device under dual antiplatelet therapy.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-04-30; most recent amendment 2025-05-30.
Status change: Recruiting → Active, Not Recruiting 2025-05-30
Status change: Not Yet Recruiting → Recruiting 2021-09-30
Trial Details
NCT Number NCT04870047
Lead Sponsor Phenox GmbH
Conditions Intracranial Aneurysm
Enrollment 171 participants
Start Date 2021-09-03
Primary Completion 2024-12-04 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-04